The Therapeutic Goods Administration (TGA) in Australia has announced that MDMA and magic mushrooms have been approved for medical use.
The TGA reclassified the drugs as “controlled drugs” which means that authorised psychiatrists will be able to prescribe the drugs for specific mental health issues from July 1st.
MDMA will only be prescribed for post-traumatic stress disorder and psilocybin for treatment-resistant depression. There is currently no TGA approved product containing either substance, so the TGA has emphasised the need for controls to protect patients during therapy.
The reclassification was seen by Dr. David Caldicott, a clinical senior lecturer in emergency medicine, as a positive step away from demonising these drugs. Approved psychiatrists will need to be approved by a human research ethics committee and the Authorized Prescriber Scheme.
GPs can refer patients to approved psychiatrists or they may be eligible for clinical trials.
This echoes Maltese MEP Cyrus Engerer’s urging of the EU last year to look into the possibility of psychedelics such as MDMA and magic mushrooms in helping to treat mental health illnesses.
Engerer told MaltaDaily in December that he is working hard to urge the EU commission to invest in more research so that the EU could be part of the forefront in the innovation in this particular field.
#MaltaDaily